Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2841

Similar articles for PubMed (Select 10574571)

1.

Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.

Udagawa N, Takahashi N, Jimi E, Matsuzaki K, Tsurukai T, Itoh K, Nakagawa N, Yasuda H, Goto M, Tsuda E, Higashio K, Gillespie MT, Martin TJ, Suda T.

Bone. 1999 Nov;25(5):517-23.

PMID:
10574571
2.

Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.

Itoh K, Udagawa N, Matsuzaki K, Takami M, Amano H, Shinki T, Ueno Y, Takahashi N, Suda T.

J Bone Miner Res. 2000 Sep;15(9):1766-75.

PMID:
10976996
3.

Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.

Tsurukai T, Udagawa N, Matsuzaki K, Takahashi N, Suda T.

J Bone Miner Metab. 2000;18(4):177-84.

PMID:
10874596
4.

The molecular basis of osteoclast differentiation and activation.

Suda T, Kobayashi K, Jimi E, Udagawa N, Takahashi N.

Novartis Found Symp. 2001;232:235-47; discussion 247-50. Review.

PMID:
11277084
5.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

PMID:
16059637
6.

Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.

Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T.

J Immunol. 1999 Jul 1;163(1):434-42.

7.
8.

Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.

Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.

J Bone Miner Res. 2000 Aug;15(8):1459-66.

PMID:
10934644
9.

A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.

Takahashi N, Udagawa N, Suda T.

Biochem Biophys Res Commun. 1999 Mar 24;256(3):449-55. Review.

PMID:
10080918
10.

A novel molecular mechanism modulating osteoclast differentiation and function.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T, Higashio K.

Bone. 1999 Jul;25(1):109-13.

PMID:
10423033
12.

Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.

Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T.

Biochem Biophys Res Commun. 1998 May 8;246(1):199-204.

PMID:
9600092
14.

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602.

15.

Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.

Karst M, Gorny G, Galvin RJ, Oursler MJ.

J Cell Physiol. 2004 Jul;200(1):99-106.

PMID:
15137062
16.

Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF).

Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A.

Biochem Biophys Res Commun. 1998 Nov 27;252(3):697-702.

PMID:
9837769
17.

NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.

Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF.

J Bone Miner Res. 2002 Jul;17(7):1200-10.

PMID:
12096833
18.

Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.

Yang S, Takahashi N, Yamashita T, Sato N, Takahashi M, Mogi M, Uematsu T, Kobayashi Y, Nakamichi Y, Takeda K, Akira S, Takada H, Udagawa N, Furusawa K.

J Immunol. 2005 Aug 1;175(3):1956-64.

19.

Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T.

J Exp Med. 2000 Jan 17;191(2):275-86.

20.

Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.

Häusler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ, Rubin JS, Gillespie MT.

J Bone Miner Res. 2004 Nov;19(11):1873-81. Epub 2004 Aug 16.

PMID:
15476588
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk